Enhancing research and treatment of mental disorders with dimensional concepts: toward DSM‐V and ICD‐11

The current versions of the DSM (DSM-IV-TR) and ICD (ICD-10) describe all mental disorders as polythetic-categorical concepts. Lists of symptoms are presented, and diagnostic category labels are assigned to patients based on observing specific patterns of symptoms. A number of notable conceptual problems emerge when using this strictly categorical system in research and in the clinic. When thorough structured diagnostic interviews are used, typical patients meet criteria for more than one specific diagnosis (a phenomenon termed "comorbidity"). In addition, groups of patients with the same putative categorical label are often heterogeneous with respect to key clinical features, such as severity and prognosis, and patients with symptomatology below diagnostic thresholds are often significantly impaired. Although categorical concepts will always be essential in official nosologies (e.g., in providing diagnostic labels for reimbursement purposes), many of the conceptual problems of a strictly categorical diagnostic system can be overcome by enhancing official nosologies with dimensional concepts. Specific dimensional approaches and directions that may be considered for upcoming revisions of both the DSM and ICD are discussed.

[1]  M. Hamilton A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[2]  E. Bos,et al.  Quantifying psychiatric comorbidity--lessions from chronic disease epidemiology. , 2002, Social psychiatry and psychiatric epidemiology.

[3]  B. Grant,et al.  DSM-IV alcohol dependence: a categorical or dimensional phenotype? , 2006, Psychological Medicine.

[4]  R. Krueger,et al.  Reinterpreting comorbidity: a model-based approach to understanding and classifying psychopathology. , 2006, Annual review of clinical psychology.

[5]  Patrick E Shrout,et al.  Synthesizing dimensional and categorical approaches to personality disorders: refining the research agenda for DSM‐V Axis II , 2007, International journal of methods in psychiatric research.

[6]  H. Wittchen,et al.  Panic attack as a risk factor for severe psychopathology. , 2004, The American journal of psychiatry.

[7]  M. First Mutually Exclusive versus Co-Occurring Diagnostic Categories: The Challenge of Diagnostic Comorbidity , 2005, Psychopathology.

[8]  A. Beautrais,et al.  Suicidal behaviour in adolescence and subsequent mental health outcomes in young adulthood , 2005, Psychological Medicine.

[9]  D. Pine,et al.  A dimensional approach to developmental psychopathology , 2007, International journal of methods in psychiatric research.

[10]  A R Feinstein,et al.  THE PRE-THERAPEUTIC CLASSIFICATION OF CO-MORBIDITY IN CHRONIC DISEASE. , 1970, Journal of chronic diseases.

[11]  H. Kraemer,et al.  DSM categories and dimensions in clinical and research contexts , 2007, International journal of methods in psychiatric research.

[12]  Mario Maj,et al.  ‘Psychiatric comorbidity’: an artefact of current diagnostic systems? , 2005, British Journal of Psychiatry.

[13]  T. Suppes,et al.  Dimensions and the psychosis phenotype , 2007, International journal of methods in psychiatric research.

[14]  R. Krueger,et al.  Symptom-based subfactors of DSM-defined conduct disorder: evidence for etiologic distinctions. , 2005, Journal of abnormal psychology.

[15]  E. Bos,et al.  Quantifying psychiatric comorbidity , 2002, Social Psychiatry and Psychiatric Epidemiology.

[16]  C. Patrick,et al.  Etiologic connections among substance dependence, antisocial behavior, and personality: modeling the externalizing spectrum. , 2002, Journal of abnormal psychology.

[17]  K. Kendler,et al.  Toward a Comprehensive Developmental Model for Major Depression in Women , 2002 .

[18]  K. Kendler Major Depression and Generalised Anxiety Disorder , 1996, British Journal of Psychiatry.

[19]  S. Lilienfeld,et al.  A Critical Examination of the Use of the Term and Concept of Comorbidity in Psychopathology Research , 1994 .

[20]  M. Höfler,et al.  What characteristics of primary anxiety disorders predict subsequent major depressive disorder? , 2004, The Journal of clinical psychiatry.

[21]  Y. Lecrubier,et al.  Relationships Among Anxiety Disorders: Patterns and Implications , 2007 .

[22]  D J Kupfer,et al.  Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations. , 1997, Archives of general psychiatry.

[23]  Scott E. Provost,et al.  Dimensional Approaches in Diagnostic Classification: Refining the Research Agenda for DSM-V , 2009 .

[24]  D I Boomsma,et al.  The co-morbidity of anxiety and depression in the perspective of genetic epidemiology. A review of twin and family studies , 2005, Psychological Medicine.

[25]  K. Bucholz,et al.  Published online in Wiley InterScience (www.interscience.wiley.com) DOI: 10.1002/mpr.210 A dimensional option for the diagnosis of substance dependence in DSM-V , 2022 .

[26]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[27]  S. Strakowski,et al.  Relationships Among Negative, Positive, and Depressive Symptoms in Schizophrenia and Psychotic Depression , 1996, British Journal of Psychiatry.

[28]  K. Kendler,et al.  The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. , 2003, Archives of general psychiatry.

[29]  D. Regier,et al.  Dimensional approaches to psychiatric classification: refining the research agenda for DSM‐V: an introduction , 2007, International journal of methods in psychiatric research.

[30]  R. Kessler,et al.  The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. , 2006, The American journal of psychiatry.

[31]  A. Gloster,et al.  Supplementary dimensional assessment in anxiety disorders , 2007, International journal of methods in psychiatric research.

[32]  J. Angst,et al.  Multimorbidity of psychiatric disorders as an indicator of clinical severity , 2002, European Archives of Psychiatry and Clinical Neuroscience.